Sei Investments CO Morpho Sys Ag Transaction History

Sei Investments CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$21.56 - $30.66 $603,680 - $858,480	-28,000 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$24.81 - $30.33 $521,010 - $636,930	-21,000 Reduced 42.86%	28,000 $794,000
Q3 2020 Nov 06, 2020	BUY	$30.28 - $35.72 $211,960 - $250,040	7,000 Added 16.67%	49,000 $1.54 Million
Q2 2020 Aug 17, 2020	SELL	$24.08 - $33.35 $168,560 - $233,450	-7,000 Reduced 14.29%	42,000 $1.33 Million
Q2 2020 Aug 11, 2020	SELL	$24.08 - $33.35 $118,136 - $163,615	-4,906 Reduced 9.1%	49,000 $1.75 Million

Q1 2020 May 14, 2020	BUY	$18.86 - $37.36 $14,277 - $28,281	757 Added 1.42%	53,906 $1.33 Million
Q4 2019 Feb 06, 2020	BUY	$26.07 - $36.32 $12,565 - $17,506	482 Added 0.92%	53,149 $1.9 Million
Q3 2019 Nov 12, 2019	SELL	$24.18 - $31.58 $141,041 - $184,206	-5,833 Reduced 9.97%	52,667 $1.45 Million
Q2 2019 Aug 14, 2019	BUY	$23.24 - $26.76 $11,620 - $13,380	500 Added 0.86%	58,500 $1.41 Million
Q1 2019 May 15, 2019	SELL	$22.55 - $29.84 $423,940 - $560,992	-18,800 Reduced 24.48%	58,000 $1.32 Million
Q3 2018 Nov 08, 2018	BUY	$26.64 - $35.66 $713,312 - $954,832	26,776 Added 53.53%	76,800 $2.05 Million
Q2 2018 Aug 03, 2018	BUY	$25.15 - $30.6 $1.26 Million - $1.53 Million	50,024 New	50,024 $1.52 Million

11.3M

320K

1.1M

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Market Cap $2.47B
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.